Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Title of 12(b) Security Title of 12(b) Security Subsequent Event Subsequent Event [Member] Schedule of Fair Value Allocation Schedule Of Fair Value Allocation [Table Text Block] Schedule Of Fair Value Allocation Adjustment to Compensation, Amount Adjustment to Compensation Amount Segment Reporting [Abstract] Segment Reporting [Abstract] Schedule of Amortization Expense Expected to be Recognized Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense [Table Text Block] Compensation Employee-related Liabilities, Current Loss contingency accrual Loss Contingency Accrual Entity Ex Transition Period Entity Ex Transition Period Insurance Accrued Insurance, Current Shares issued upon vesting of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Number of securities called by warrants (in shares) Warrants, common shares issuable (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Schedule of Prepaid Expenses and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Offering costs recorded to debt discount Offering Costs Recorded To Debt Discount Offering Costs Recorded To Debt Discount Debt instrument, convertible, conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Debt instrument, interest rate, default Debt Instrument, Interest Rate, Default Debt Instrument, Interest Rate, Default Maidson Madison [Member] Madison Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Developed technology Developed Technology Rights [Member] Fair value adjustment of warrants Fair Value Adjustment of Warrants CEF Purchase Agreement CEF Purchase Agreement [Member] The element represents c e f purchase agreement member. Property and equipment Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment Inventory, write-off, number of batches Inventory, Write-Off, Number of Batches Inventory, Write-Off, Number of Batches Scott Plesha [Member] Scott Plesha Other comprehensive (loss) income: Other Comprehensive Income (Loss), Net of Tax [Abstract] Drug product manufacturing subcontractor Prepaid Drug Product Manufacturing Subcontractor, Current Prepaid Drug Product Manufacturing Subcontractor, Current Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Asset Acquisition [Axis] Asset Acquisition [Axis] Nonvested restricted stock options (in shares) Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Proceeds from royalties, obtaining threshold Revenue, Remaining Performance Obligation, Variable Consideration, Net Sales Threshold Revenue, Remaining Performance Obligation, Variable Consideration, Net Sales Threshold Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current Work-in-process Inventory, Work in Process, Net of Reserves Zelsuvmi Royalty Agreement ZELSUVMI License [Member] ZELSUVMI License Entity Address, City or Town Entity Address, City or Town Conversion price Measurement Input, Conversion Price [Member] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Number of additional PIPE investors Number Of Additional PIPE Investors Number Of Additional PIPE Investors Net product revenues Product [Member] Intangible assets, net Total definite-lived intangible assets Intangible Asset, Finite-Lived, after Accumulated Amortization Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] License License [Member] Debt instrument, convertible, days prior to consummation of change of control Debt Instrument, Convertible, Days Prior To Consummation Of Change Of Control Debt Instrument, Convertible, Days Prior To Consummation Of Change Of Control Subsequent Event Type [Axis] Subsequent Event Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Error Correction [Table] Error Correction [Table] Schedule of Segment Reporting Segment Reporting [Table Text Block] Finite-lived intangible assets, term extension Finite-Lived Intangible Assets, Term Extension Finite-Lived Intangible Assets, Term Extension Use of Estimates Use of Estimates, Policy [Policy Text Block] Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Axis] Change in fair value of convertible debt due to instrument credit risk Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Debt Instrument, Redemption, Period Two Debt Instrument, Redemption, Period Two [Member] Pledge agreement, percentage of aggregate net sales of end product Pledge Agreement, Percentage Of Aggregate Net Sales Of End Product Pledge Agreement, Percentage Of Aggregate Net Sales Of End Product Proceeds from loan payable, net of debt discount Proceeds from Debt, Net of Issuance Costs Document Period End Date Document Period End Date Preferred stock, shares outstanding (in shares) Beginning balance, preferred shares (in shares) Ending balance, preferred shares (in shares) Preferred Stock, Shares Outstanding Debt face amount Debt Instrument, Face Amount Effective interest rate (in percent) Debt Instrument, Interest Rate, Effective Percentage Convertible notes payable - related party Convertible debt Convertible Debt Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Consolidation Items [Domain] Consolidation Items [Domain] Deferred tax liability Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liability Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liability Change in fair value recognized in net loss Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Operating lease liabilities, current portion Operating Lease, Liability, Current Schedule of Outstanding Securities and Issuable Common Shares Schedule of Outstanding Securities and Issuable Common Shares [Table Text Block] Schedule of Outstanding Securities and Issuable Common Shares Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Discount rate Measurement Input, Discount Rate [Member] Ferrer License Agreement Ferrer License Agreement [Member] Ferrer License Agreement Intangible Asset, Including Goodwill, after Accumulated Amortization [Abstract] Intangible Asset, Including Goodwill, after Accumulated Amortization [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment License agreement, written notice for bankruptcy or insolvency events, period License Agreement, Written Notice For Bankruptcy or Insolvency Events, Period License Agreement, Written Notice For Bankruptcy or Insolvency Events, Period Debt instrument, senior rank, indebtedness, maximum Debt Instrument, Senior Rank, Indebtedness, Maximum Debt Instrument, Senior Rank, Indebtedness, Maximum Schedule of Tangible and Intangible Assets Acquired and Liabilities Assumed Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block] Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] Income Tax Disclosure [Abstract] John M. Gay [Member] John M. Gay Credit Facility [Domain] Credit Facility [Domain] Debt instrument, repayment prohibition lifted, period following repayment of term loan Debt Instrument, Repayment Prohibition Lifted, Period Following Repayment Of Other Debt Debt Instrument, Repayment Prohibition Lifted, Period Following Repayment Of Other Debt Cash flow from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] License and collaboration revenues License and Collaboration [Member] License and Collaboration Percent royalty based on net sales License And Supply Agreement, Royalty Based On Net Sales, Percent Percentage Of Royalty On Net Sales Accrued liabilities Business Combination, Recognized Liability Assumed, Accrued Liabilities, Current Business Combination, Recognized Liability Assumed, Accrued Liabilities, Current Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Fair value of net assets acquired Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Line of Credit Facility [Table] Line of Credit Facility [Table] Amended Sato license Sato Payments Amended Sato License Sato License [Member] Sato License Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Prior to the Expiration of Initial Royalty Term Prior to the Expiration of Initial Royalty Term [Member] Prior to the Expiration of Initial Royalty Term Balance Sheet Related Disclosures [Line Items] Balance Sheet Related Disclosures [Line Items] Balance Sheet Related Disclosures Goodwill, expected tax deductible, amount Business Combination, Goodwill, Expected Tax Deductible, Amount Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Contractual Amount Asset Acquisition, Contractual Amount [Member] Asset Acquisition, Contractual Amount UNC UNC [Member] UNC Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Asset Acquisition, Contingent Consideration, Type [Domain] Asset Acquisition, Contingent Consideration, Type [Domain] Asset Acquisition, Contingent Consideration, Type [Domain] Award Timing Predetermined Award Timing Predetermined [Flag] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Debt Instrument, Repayment, Period Two Debt Instrument, Repayment, Period Two [Member] Debt Instrument, Repayment, Period Two Effective income tax rate reconciliation, percent Effective Income Tax Rate Reconciliation, Percent Fair Value Measurements and Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Company specific risk premium Debt Instrument, Company Specific Risk Premium, Percent Debt Instrument, Company Specific Risk Premium, Percent Operating lease liabilities Increase (Decrease) in Operating Lease Liability Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Depreciation of property and equipment Depreciation Depreciation Plan Name [Domain] Plan Name [Domain] Total, debt Long Term Debt, Fair Value Allocation, Net Long Term Debt, Fair Value Allocation, Net Antidilutive Securities [Axis] Antidilutive Securities [Axis] Scenario [Domain] Scenario [Domain] Stock options, outstanding (in dollars per share) Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Black-Scholes Valuation Technique, Black-Scholes-Merton Model [Member] Operating lease right-of-use assets, net Operating Lease, Right-of-Use Asset STOCKHOLDERS’ EQUITY Shareholders' Equity and Share-Based Payments [Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] License and supply agreement, initial term License And Supply Agreement, Initial Term License And Supply Agreement, Initial Term Convertible debt, common shares issuable (in shares) Debt Instrument, Convertible, Number of Equity Instruments Consideration transferred Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Growth percentage Revenue From Contract With Customer, Excluding Assessed Tax, Quarterly Growth Percentage Revenue From Contract With Customer, Excluding Assessed Tax, Quarterly Growth Percentage Expiration Date Trading Arrangement Expiration Date Net increase (decrease) in cash and cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation 2030 Long-Term Debt, Maturity, Year Four Securities Purchase Agreements Securities Purchase Agreements [Member] Securities Purchase Agreements Payment-in-kind on convertible debt Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Payment In Kind Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Payment In Kind Contingent consideration Asset Acquisition, Contingent Consideration, Liability, Current Nonrelated Party Nonrelated Party [Member] Asset Acquisition Consideration Type [Domain] Asset Acquisition Consideration Type [Domain] Asset Acquisition Consideration Type [Domain] Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Payables Settlement and Expenses PIPE Proceeds Allocated To Fees & Accounts Payable PIPE Proceeds Allocated To Fees & Accounts Payable Accounts receivable Business Combination, Recognized Asset Acquired, Receivable, Current Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Cash flow from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Accrued gross-to-net adjustments Accrued Gross-to-Net Adjustments, Current Accrued Gross-to-Net Adjustments, Current Net loss Business Combination, Pro Forma Information, Pro Forma Income (Loss), after Tax Unamortized Expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Segments [Domain] Segments [Domain] Underwriter Warrants Underwriter Warrants [Member] Underwriter Warrants Cash, cash equivalents and restricted cash as of beginning of period Cash, cash equivalents and restricted cash as of end of period Total cash, cash equivalents and restricted cash shown in the statement of cash flows Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation NOTES PAYABLE Debt Disclosure [Text Block] U.S. Patents Covering ZELSUVMI U.S. Patents Covering ZELSUVMI [Member] U.S. Patents Covering ZELSUVMI Debt discount rate Debt Instrument, Discount Rate, Percent Debt Instrument, Discount Rate, Percent Scenario [Axis] Scenario [Axis] Royalty financing obligations - related party Carrying value at December 31, 2025 Carrying value at June 30, 2026 Contractual Obligation Research and Development operations Research And Development Operations Segment [Member] Research And Development Operations Segment Business Combination [Table] Business Combination [Table] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Percentage modification notice period Debt Instrument, Convertible, Percent Of Shares Owned, Modification Notice Period Debt Instrument, Convertible, Percent Of Shares Owned, Modification Notice Period Secured Debt Secured Debt [Member] Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] Notes Settlement PIPE Proceeds Allocated To Debt Payable PIPE Proceeds To Debt Payable Total operating expenses Costs and Expenses Stated percentage Debt Instrument, Interest Rate, Stated Percentage Total stockholders' (deficit) equity Beginning balance Ending balance Equity, Attributable to Parent Other assets Business Combination, Recognized Asset Acquired, Other Asset, Noncurrent Reedy Creek Reedy Creek [Member] Reedy Creek ASSETS Assets [Abstract] Number of shares issued in business combination (in shares) Shares of Series A Preferred Stock issued in the Merger Agreement (in shares) Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares Professional fees Professional Fees Insider Trading Policies and Procedures [Line Items] Performance Shares Performance Shares [Member] Prepaid expenses and other current assets Total prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] BALANCE SHEET ACCOUNT DETAILS Supplemental Balance Sheet Disclosures [Text Block] Business acquisition, percentage of business owned after merger Business Acquisition, Percentage of Business Owned After Merger Business Acquisition, Percentage of Business Owned After Merger Expected dividend yield Measurement Input, Expected Dividend Rate [Member] Number of operating segments Number of Operating Segments Antidilutive securities excluded from computation of earnings per share, amount (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Contract termination material breach, advance written notice period Revenue from Contract with Customer, Contract Termination Material Breach, Advance Written Notice Period Revenue from Contract with Customer, Contract Termination Material Breach, Advance Written Notice Period Carrying Value Goodwill, Gross Entity Central Index Key Entity Central Index Key Less: Accumulated depreciation and amortization Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization Equity [Abstract] Equity [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Payments for legal settlements Payments for Legal Settlements 2026 (April 1 - December 31) Long-Term Debt, Maturity, Remainder of Fiscal Year After the Expiration of Initial Royalty Term After the Expiration of Initial Royalty Term [Member] After the Expiration of Initial Royalty Term Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Number of third-party lenders Line of Credit Facility, Number Of Third-Party Lenders Line of Credit Facility, Number Of Third-Party Lenders Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate License and supply agreement, renewal term License And Supply Agreement, Renewal Term License And Supply Agreement, Renewal Term Debt Instrument, Redemption, Period One Debt Instrument, Redemption, Period One [Member] Accumulated Other Comprehensive Income AOCI Attributable to Parent [Member] All Individuals All Individuals [Member] Horizon Warrants Horizon Warrants [Member] Horizon Warrants Finished goods Inventory, Finished Goods, Net of Reserves Remaining Life Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Prior Presentation Previously Reported [Member] Balance Sheet Related Disclosures [Abstract] Debt Instrument, Repayment, Period [Axis] Debt Instrument, Repayment, Period [Axis] Debt Instrument, Repayment, Period Statement [Line Items] Statement [Line Items] Total assets Total assets Assets Website development Website Development Website Development [Member] Website Development Common shares issuable (in shares) Common Stock, Capital Shares Reserved for Future Issuance Convertible Debt Convertible Debt [Member] Operating Segments Operating Segments [Member] Weighted-average fair value per option (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Interest expense Interest Expense, Nonoperating Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] PEO PEO [Member] 2028 Long-Term Debt, Maturity, Year Two Prepaid expenses Increase (Decrease) in Prepaid Expense Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Other long-term liabilities Total other long-term liabilities Other Liabilities, Noncurrent Goodwill Goodwill Net Book Value Goodwill Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Accounts payable Business Combination, Recognized Liability Assumed, Accounts Payable, Current Accumulated Deficit Retained Earnings [Member] Operating lease liabilities, net of current portion Operating Lease, Liability, Noncurrent Total, warrants Warrant Liability, Fair Value Allocation, Net Warrant Liability, Fair Value Allocation, Net Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, shares, outstanding (in shares) Beginning balance, common shares (in shares) Ending balance, common shares (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Warrants issued for venture loan and security agreement Warrants Issued Warrants Issued Net loss per common share, diluted (in dollars per share) Earnings Per Share, Diluted Convertible Notes Convertible Notes [Member] Convertible Notes Change in accrued compensation Increase (Decrease) in Employee Related Liabilities Litigation Case [Domain] Litigation Case [Domain] Amortization of intangible assets Amortization of intangible assets Amortization of intangible assets Intangible Asset, Finite-Lived, Amortization Expense Intangible Asset, Finite-Lived [Line Items] Intangible Asset, Finite-Lived [Line Items] Deferred offering costs Deferred Offering Costs Operating lease right-of-use assets Increase (Decrease) In Operating Lease Right-Of-Use Assets Increase (Decrease) In Operating Lease Right-Of-Use Assets Channel Products Royalty Agreement Channel Covered Products License [Member] Channel Covered Products License Finite-lived intangible assets acquired Intangible Asset, Finite-Lived, Acquired IPO IPO [Member] Total revenue Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] 2031 and thereafter Long-Term Debt, Maturity, Year Five And Thereafter Long-Term Debt, Maturity, Year Five And Thereafter Contingent Consideration - Achievement of Commercial Quantities Contingent Consideration - Achievement Of Commercial Quantities [Member] Contingent Consideration - Achievement Of Commercial Quantities Construction-in-progress Construction in Progress [Member] Number of approved products Number Of FDA Approved Products Number Of FDA Approved Products Debt instrument, convertible, percent of shares owned after conversion, maximum Debt Instrument, Convertible, Percent Of Shares Owned After Conversion, Maximum Debt Instrument, Convertible, Percent Of Shares Owned After Conversion, Maximum Schedule of Maturities of Long-Term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Equity Method Investment [Table] Equity Method Investment [Table] Sale of Stock [Axis] Sale of Stock [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Other (expense) income Other Nonoperating Income (Expense) [Abstract] Operating loss Operating Income (Loss) Revenue, performance obligation, amount Revenue, Remaining Performance Obligation, Amount Income received through royalty Revenue, Remaining Performance Obligation, Variable Consideration, Percent Of Non-Royalty Sublicense Income Revenue, Remaining Performance Obligation, Variable Consideration, Percent Of Non-Royalty Sublicense Income PIK period (years) Measurement Input, Paid-in-Kind Period [Member] Measurement Input, Paid-in-Kind Period ACQUISITION OF LNHC, INC. Business Combination [Text Block] Royalty agreement, percent of sales Royalty Agreement, Variable Consideration, Percent Of Net Sales Royalty Agreement, Variable Consideration, Percent Of Net Sales Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, shares, issued (in shares) Common Stock, Shares, Issued Ferrer Internacional, S. A. & Interquim, S. A. U. Ferrer Internacional, S. A. And Interquim, S. A. U. [Member] Ferrer Internacional, S. A. And Interquim, S. A. U. Ligand Royalty Agreement Ligand Royalty Agreement [Member] Ligand Royalty Agreement Ferrer Ferrer [Member] Ferrer Accounts receivable Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Class of Stock [Line Items] Class of Stock [Line Items] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Contractual obligation, measurement input Contractual Obligation, Measurement Input Contractual Obligation, Measurement Input License agreement, material breach uncured, period License Agreement, Material Breach Uncured, Period License Agreement, Material Breach Uncured, Period Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Termination Date Trading Arrangement Termination Date Debt, allocated fair value Long-Term Debt, Fair Value Allocation, Amount Long-Term Debt, Fair Value Allocation, Amount Intangible assets Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Finite-Lived Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Stock split, conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Patient assistance platforms Patient Assistance Platforms, Current Patient Assistance Platforms, Current Other liabilities Total other liabilities Other Liabilities, Current Stock options expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Three Customers Three Customers [Member] Three Customers Accrued expenses Total accrued expenses Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Redemption price, percentage Debt Instrument, Redemption Price, Percentage Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Deferred revenue, current portion Business Combination, Recognized Liability Assumed, Deferred Revenue, Current Arrangement Duration Trading Arrangement Duration Contractual obligation, noncurrent Carrying value at June 30, 2026, net of current portion Contractual Obligation, Noncurrent Contractual Obligation, Noncurrent Consolidation Items [Axis] Consolidation Items [Axis] Intangible Asset, Indefinite-Lived, Acquired [Table] Intangible Asset, Indefinite-Lived, Acquired [Table] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Ligand Assignment Agreement Amendment Ligand Assignment Agreement Amendment [Member] Ligand Assignment Agreement Amendment Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Vest and expected, outstanding, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Definite-lived intangible assets Carrying Value Intangible Asset, Finite-Lived, before Accumulated Amortization Change in accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Business combination, consideration transferred, liabilities settled Business Combination, Consideration Transferred, Liabilities Settled Business Combination, Consideration Transferred, Liabilities Settled Working capital deficit Working Capital The element represents working capital Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Furniture and fixtures Furniture and Fixtures [Member] Intangible Asset, Finite-Lived, Class [Domain] Intangible Asset, Finite-Lived, Class [Domain] Change in fair value of convertible debt Change in fair value of convertible notes Change In Fair Value Of Convertible Debt Change In Fair Value Of Convertible Debt Exercisable (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term 2031 and thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four All Award Types Award Type [Domain] Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term 2027 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One Accrued expenses Change in accrued expenses Increase (Decrease) in Accrued Liabilities Total merger consideration Business Combination, Consideration Transferred, Equity Interest, Share Issued, Value Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Legal Entity [Axis] Legal Entity [Axis] Interest expense, debt Interest Expense, Debt Schedule of Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block] Liability Class [Axis] Liability Class [Axis] Prescription Drug User Fee Act (PDUFA) fees Prepaid Prescription Drug User Fee Act Fees, Current Prepaid Prescription Drug User Fee Act Fees, Current Contingent consideration, number of milestone payments Asset Acquisition, Number Of Contingent Milestones Asset Acquisition, Number Of Contingent Milestones Operating lease right-of-use assets Business Combination, Recognized Assets Acquired, Operating Lease Right-of-Use Assets Business Combination, Recognized Assets Acquired, Operating Lease Right-of-Use Assets Intangible Asset, Finite-Lived [Table] Intangible Asset, Finite-Lived [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] UNC License UNC License [Member] UNC License Non-NEOs Non-NEOs [Member] License and supply agreement, purchase requirement, percentage License And Supply Agreement, Purchase Requirement, Percentage License And Supply Agreement, Purchase Requirement, Percentage Biofrontera Biofrontera Inc. [Member] Biofrontera Inc. 2028 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two Warrant, period following commencement date, exercisable Class Of Warrant Or Right, Period Following Commencement Date, Exercisable Class Of Warrant Or Right, Period Following Commencement Date, Exercisable Contingent consideration Asset Acquisition, Consideration Transferred, Contingent Consideration Customer [Domain] Customer [Domain] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] 2027 Long-Term Debt, Maturity, Year One Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] License and supply agreement, purchase obligation, forecast period License And Supply Agreement, Purchase Obligation, Forecast Period License And Supply Agreement, Purchase Obligation, Forecast Period Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Deferred revenue, current portion Contract with Customer, Liability, Current Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Payments for initial supply License And Supply Agreement, Payments For Initial Supply License And Supply Agreement, Payments For Initial Supply Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Warrants issued for venture loan and security agreement Adjustments to Additional Paid in Capital, Warrant Issued Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Trading days Debt Instrument, Convertible, Threshold Trading Days Total, allocated fair value Debt Instruments And Warrants, Fair Value Allocation, Amount Debt Instruments And Warrants, Fair Value Allocation, Amount Liquidated Damages Liquidated Damages [Member] Liquidated Damages Third Party Facility Third Party Facility [Member] Third Party Facility Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Proceeds from venture loan and security agreement, net Proceeds from Issuance of Secured Debt Common Shares Common Stock [Member] Short-term Bridge loan Business Combination, Recognized Liability Assumed, Long-Term Debt, Current Debt instrument, event of default, potential increase in interest rate Debt Instrument, Event Of Default, Potential Increase In Interest Rate Debt Instrument, Event Of Default, Potential Increase In Interest Rate Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Xepi Xepi [Member] Xepi Number of products acquired Number Of Products Acquired Number Of Products Acquired License and supply agreement, initial supply amount License And Supply Agreement, Initial Supply Amount License And Supply Agreement, Initial Supply Amount Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] License and supply agreement, binding forecast period License And Supply Agreement, Purchase Obligation, Binding Forecast Period License And Supply Agreement, Purchase Obligation, Binding Forecast Period Schedule of Loss on Issuance of Convertible Note Convertible Debt [Table Text Block] Debt Instrument, Repayment, Period Three Debt Instrument, Repayment, Period Three [Member] Debt Instrument, Repayment, Period Three Total liabilities and stockholders' equity Liabilities and Equity Preferred stock, common shares issuable (in shares) Preferred Stock, Convertible, Shares Issuable Stock options Stock options Share-Based Payment Arrangement, Option [Member] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Related and Nonrelated Parties [Domain] Related and Nonrelated Parties [Domain] Drug product manufacturing subcontractor Drug Product Manufacturing Subcontractor, Current Drug Product Manufacturing Subcontractor, Current Tabular List, Table Tabular List [Table Text Block] Additional paid in capital Additional Paid in Capital Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 2029 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three 2026 (July 1 - December 31) Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Beginning balance of aggregate intrinsic value Ending balance of aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Schedule of Other Current Liabilities Other Current Liabilities [Table Text Block] Long-Lived Asset, Class [Domain] Long-Lived Asset, Class [Domain] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Sale of preferred stock price per share (in dollars per share) Sale of Stock, Price Per Share Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Debt instrument, measurement input Debt Instrument, Measurement Input Preferred stock, value Preferred Stock, Value, Issued Asset-Based Loan Facility Asset-Based Loan Facility [Member] Asset-Based Loan Facility Adjustment to Compensation: Adjustment to Compensation [Axis] Cost of Goods Sold Cost of Goods and Service [Policy Text Block] Asset Acquisition, Contingent Consideration, Type [Axis] Asset Acquisition, Contingent Consideration, Type [Axis] Asset Acquisition, Contingent Consideration, Type Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Upfront Payment - Asset Purchase Agreement Payments to Acquire Productive Assets Cash paid for interest expense Interest Paid, Excluding Capitalized Interest, Operating Activity Credit Facility [Axis] Credit Facility [Axis] Name Measure Name Commercial, marketing and sales Accrued Commercial, Marketing And Sales, Current Accrued Commercial, Marketing And Sales, Current Pay vs Performance Disclosure [Line Items] Debt Instrument [Line Items] Debt Instrument [Line Items] LNHC, Inc. LNHC, Inc. [Member] LNHC, Inc. Additional Paid-in Capital Additional Paid-in Capital [Member] Name Trading Arrangement, Individual Name Developed Technology Developed Technology [Member] Developed Technology Cash and cash equivalents Cash and Cash Equivalent Expected term (in years) Measurement Input, Expected Term [Member] Raw materials Inventory, Raw Materials, Net of Reserves Company Selected Measure Amount Company Selected Measure Amount Accrued milestone payments License Agreement, Accrued Milestone Payments, Current License Agreement, Accrued Milestone Payments, Current Vested and expected (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Interest accretion Contractual Obligation, Liability, Interest Accretion Contractual Obligation, Liability, Interest Accretion Allocated Purchase Price Asset Acquisition, Allocated Purchase Price [Member] Asset Acquisition, Allocated Purchase Price Non-PEO NEO Non-PEO NEO [Member] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Customer Concentration Risk Customer Concentration Risk [Member] Cost of goods sold Cost of goods sold Cost of Product and Service Sold Award Timing Method Award Timing Method [Text Block] Forecast Forecast [Member] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Royalty agreement, percent of non-royalty sublicensing payments Royalty Agreement, Variable Consideration, Percent Of Non-Royalty Sublicensing Payments Royalty Agreement, Variable Consideration, Percent Of Non-Royalty Sublicensing Payments Bridge Loan Bridge Loan [Member] Restatement Determination Date: Restatement Determination Date [Axis] Xepi Transaction Xepi Transaction [Member] Xepi Transaction Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Change in fair value recognized in other comprehensive income Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) Consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Contingent Consideration - Acceptance of Initial API Purchase Contingent Consideration - Acceptance Of Initial API Purchase [Member] Contingent Consideration - Acceptance Of Initial API Purchase Number of patents Number Of Patents Obtained Number Of Patents Obtained Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Revenue Revenues [Abstract] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Schedule of Intangible Asset and Goodwill Intangible Asset and Goodwill [Table Text Block] Asset Acquisition [Table] Asset Acquisition [Table] Statistical Measurement [Domain] Statistical Measurement [Domain] Schedule of Merger and PIPE Financing Activities Schedule Of Merger And PIPE Financing Activities [Table Text Block] Schedule Of Merger And PIPE Financing Activities Shares issued for services Stock Issued During Period, Value, Issued for Services Document Fiscal Year Focus Document Fiscal Year Focus Revenue, remaining balance Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period License agreement, required regulatory and commercial milestone payments License Agreement, Required Regulatory And Commercial Milestone Payments, Maximum License Agreement, Required Regulatory And Commercial Milestone Payments, Maximum RSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Customer [Axis] Customer [Axis] XEGLYZE Asset Purchase Agreement Xeglyze Asset Purchase Agreement [Member] Xeglyze Asset Purchase Agreement Common stock, value Common Stock, Value, Issued Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Line of Credit Line of Credit [Member] Restatement Determination Date Restatement Determination Date Indefinite-lived intangible assets Goodwill, Impaired, Accumulated Impairment Loss [Abstract] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Inventory write-off Inventory Write-down Vested and expected (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Convertible debt, shares issuable upon final conversion (in shares) Debt Instrument, Convertible, Shares Issuable Upon Final Conversion Debt Instrument, Convertible, Shares Issuable Upon Final Conversion Amendment Flag Amendment Flag Novan Novan [Member] Novan Shares issued for cash (in shares) Stock Issued During Period, Shares, Other Intangible Assets, Net and Goodwill Goodwill and Intangible Assets, Policy [Policy Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Upfront payment License And Supply Agreement, Payments For Upfront Payment License And Supply Agreement, Payments For Upfront Payment Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Entity Address, State or Province Entity Address, State or Province Preferred stock series C Series C Preferred Stock [Member] Royalty Payments on Net Sales of Xepi Asset Acquisition, Royalty Payment On Net Sales, Percent Asset Acquisition, Royalty Payment On Net Sales, Percent PEO Total Compensation Amount PEO Total Compensation Amount Weighted average number of common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Clinical development activities Prepaid Clinical Development Activities, Current Prepaid Clinical Development Activities, Current Schedule of Related Party Transactions Schedule of Related Party Transactions [Table Text Block] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Convertible notes payable - related party Convertible notes payable - related party (Note 7) Convertible Debt, Noncurrent Change to maximum percentage ownership, notice period Preferred Stock, Change To Maximum Percentage Ownership, Notice Period Preferred Stock, Change To Maximum Percentage Ownership, Notice Period Preferred stock, convertible, percentage of IPO price Preferred Stock, Convertible, Percentage Of IPO Price Preferred Stock, Convertible, Percentage Of IPO Price Consideration transferred Consideration transferred Asset Acquisition, Consideration Transferred Sato Pharmaceutical Company Sato [Member] Sato Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Class of Stock [Axis] Class of Stock [Axis] Payments for royalties Payments for Royalties Royalty agreement, prior notice period for terminate Royalty Agreement, Termination Notice Period Royalty Agreement, Termination Notice Period Revenue from Contract with Customer Benchmark Revenue from Contract with Customer Benchmark [Member] Less: accumulated amortization Accumulated Amortization Intangible Asset, Finite-Lived, Accumulated Amortization Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Long-term debt, current maturities Long-Term Debt, Current Maturities Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Basic and Diluted Net Loss per Common Share Earnings Per Share, Policy [Policy Text Block] Litigation Case [Axis] Litigation Case [Axis] Upfront payment payable License And Supply Agreement, Upfront Payment Payable License And Supply Agreement, Upfront Payment Payable Purchases of property and equipment with accounts payable and accrued expenses Capital Expenditures Incurred but Not yet Paid Deferred revenue Increase (Decrease) in Contract with Customer, Liability Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Commercial data platforms Commercial Data Platforms, Current Commercial Data Platforms, Current Total Long-Term Debt Warrant exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Channel Products Royalty Agreement NRV, Ligand & Madison [Member] NRV, Ligand & Madison Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Financial reporting platforms Financial Reporting Platforms, Current Financial Reporting Platforms, Current Warrants issuable, percent of debt divided by exercise price Class Of Warrant Or Right, Warrants Issuable, Percent Of Debt Divided By Exercise Price Class Of Warrant Or Right, Warrants Issuable, Percent Of Debt Divided By Exercise Price Security Exchange Name Security Exchange Name Contractual obligation, current Less: current portion Contractual Obligation, Current Contractual Obligation, Current Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Final Payment Venture Loan And Security Agreement, Term Loans, Final Payment [Member] Venture Loan And Security Agreement, Term Loans, Final Payment Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Contingent Consideration - Achievement of Sales Based Milestones Contingent Consideration - Achievement Of Sales Based Milestones [Member] Contingent Consideration - Achievement Of Sales Based Milestones Common shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Shares issued for services (in shares) Stock Issued During Period, Shares, Issued for Services Accrued interest Interest Payable, Current Schedule of Property, Plant and Equipment Property, Plant, and Equipment [Table Text Block] Name Outstanding Recovery, Individual Name Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Venture loan and security agreement, net Secured Long-Term Debt, Noncurrent Number of monthly payments Debt Instrument, Number Of Monthly Payments Debt Instrument, Number Of Monthly Payments Ligand Facility Ligand Facility [Member] Ligand Facility Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Line of credit facility, remaining borrowing capacity, portion subject to milestone achievement Line of Credit Facility, Remaining Borrowing Capacity, Portion Subject To Milestone Achievement Line of Credit Facility, Remaining Borrowing Capacity, Portion Subject To Milestone Achievement Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Supplemental non-cash investing and financing activities: Noncash Investing and Financing Items [Abstract] Venture Loan and Security Agreement, gross Total Long-Term Debt, Gross Venture Loan And Security Agreement, Term Loans Term Loan Venture Loan And Security Agreement, Term Loans [Member] Venture Loan And Security Agreement, Term Loans Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Warrants to purchase common stock Warrant [Member] Percentage of voting interest acquired Business Combination, Voting Equity Interest Acquired, Percentage Weighted average number of common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Entity Emerging Growth Company Entity Emerging Growth Company Related Party Transaction [Line Items] Related Party Transaction [Line Items] Deferred revenue, long-term portion Business Combination, Recognized Liability Assumed, Deferred Revenue, Long-term Portion Business Combination, Recognized Liability Assumed, Deferred Revenue, Long-term Portion Underlying Security Market Price Change Underlying Security Market Price Change, Percent Revenue from Contract with Customer [Abstract] Venture Loan and Security Agreement, gross Venture Loan And Security Agreement [Member] Venture Loan And Security Agreement Amended Sato license Sato License, Net of Impairment [Member] Sato License, Net of Impairment Restricted cash Restricted cash Restricted Cash, Current Indefinite-Lived Intangible Assets [Line Items] Intangible Asset, Goodwill and Other [Abstract] Series A Preferred Shares Issued Preferred A Shares Issued [Roll Forward] Preferred A Shares Issued Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Third party fees Debt Instrument, Third Party Fee Amount Debt Instrument, Third Party Fee Amount Assignment agreement, percentage of other amounts received payable Assignment Agreement, Percentage Of Other Amounts Received Payable Assignment Agreement, Percentage Of Other Amounts Received Payable Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value All Executive Categories All Executive Categories [Member] Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Funding received Research and Development Arrangement, Funding Received Research and Development Arrangement, Funding Received Commitment fee Line of Credit Facility, Commitment Fee Amount Asset Acquisition [Domain] Asset Acquisition [Domain] Preferred stock conversion price (in dollars per share) Preferred Stock, Convertible, Conversion Price Debt Disclosure [Abstract] Debt Disclosure [Abstract] Two Thousand Twenty Three Plan Two Thousand Twenty Three Plan [Member] Two Thousand Twenty Three Plan Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value SEGMENT INFORMATION Segment Reporting [Text Block] Minimum Minimum [Member] Zelsuvmi Royalty Agreement Nomis RoyaltyVest LC [Member] Nomis RoyaltyVest LC Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Location, Statement of Income, Balance [Axis] Location, Statement of Income, Balance [Axis] Debt instrument, prepayment premium, percent Debt Instrument, Prepayment Premium, Percent Debt Instrument, Prepayment Premium, Percent Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Outstanding (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Customer Two Customer Two [Member] Customer Two Business Combination [Line Items] Business Combination [Line Items] Asset Acquisition Consideration Type [Axis] Asset Acquisition Consideration Type [Axis] Asset Acquisition Consideration Type Common stock, shares authorized (in shares) Common Stock, Shares Authorized Remaining Useful Life (Years) Intangible Asset, Finite-Lived, Useful Life Xeglyze Xeglyze Transaction Intangible Asset [Member] Xeglyze Transaction Intangible Asset Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Schedule of Carrying Value of Loan Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] Exercise Price Award Exercise Price Development rights, period Royalty Agreement, Development Rights, Period Royalty Agreement, Development Rights, Period Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Segment Reporting [Line Items] Segment Reporting [Line Items] Convertible Investors Convertible Investors [Member] Convertible Investors Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Subordination premium Debt Instrument, Subordination Premium, Percent Debt Instrument, Subordination Premium, Percent Revenue from contract with customer, renewal period Revenue From Contract With Customer, Renewal Period Revenue From Contract With Customer, Renewal Period Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Equity Component [Domain] Equity Component [Domain] Measurement Input Type [Domain] Measurement Input Type [Domain] Allocated gross proceeds Allocated Gross Proceeds Proceeds From PIPE, Gross Proceeds From PIPE, Gross Schedule of Debt Discount Rate Debt Discount Rate [Table Text Block] Debt Discount Rate Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Adoption Date Trading Arrangement Adoption Date Inventory Inventory, Policy [Policy Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Total other expense Nonoperating Income (Expense) Insurance Prepaid Insurance Contingent consideration Asset Acquisition, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Asset Acquisition, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Number of commercial products actively promoted Number Of Commercial Products Actively Promoted Number Of Commercial Products Actively Promoted Dr Lang Employment Contract Dr Lang Employment Contract [Member] Dr Lang Employment Contract Lender fees Debt Instrument, Fee Amount Debt instrument, variable rate, floor Debt Instrument, Variable Rate, Floor Debt Instrument, Variable Rate, Floor Accounting Policies [Abstract] Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Balance Sheet Related Disclosures [Table] Balance Sheet Related Disclosures [Table] Balance Sheet Related Disclosures Weighted-average fair value per option Measurement Input, Weighted Average Fair Value Per Option [Member] Measurement Input, Weighted Average Fair Value Per Option Royalty agreement, milestone Revenue, Remaining Performance Obligation, Variable Consideration Amount Revenue, Remaining Performance Obligation, Variable Consideration Amount Stock options, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Debt conversion to equity, value Debt Conversion To Equity, Value Debt Conversion To Equity, Value Selling, general and administrative Selling, general and administrative Selling, General and Administrative Expense Schedule of Reclassifications Made to Prior-Period Financial Statements Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] Business Combination [Domain] Business Combination [Domain] Common stock, increase (decrease) in capital shares reserved for future issuance (in shares) Common Stock, Increase (Decrease) In Capital Shares Reserved for Future Issuance Common Stock, Increase (Decrease) In Capital Shares Reserved for Future Issuance Convertible fees allocated to royalty Contractual Obligation, Liability, Convertible Fees Allocated To Royalty Contractual Obligation, Liability, Convertible Fees Allocated To Royalty COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Nonvested restricted stock units RSUs Restricted stock units Restricted Stock Units (RSUs) [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] All Adjustments to Compensation All Adjustments to Compensation [Member] Business Combination [Axis] Business Combination [Axis] REEDY CREEK LIABILITY Research, Development, and Computer Software Disclosure [Text Block] Net cash used in operating activities Net cash provided by (used in) operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Accounts Receivable Accounts Receivable [Member] Income Statement [Abstract] Income Statement [Abstract] STOCKHOLDERS’ EQUITY Equity, Attributable to Parent [Abstract] Zelsuvmi Royalty Agreement ZELSUVMI Royalty Agreement [Member] ZELSUVMI Royalty Agreement Software Software, Purchased [Member] Document Transition Report Document Transition Report Operating expenses Operating Expenses [Abstract] Commercial operations Commercial Operations Segment [Member] Commercial Operations Segment Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Ligand Ligand [Member] Ligand City Area Code City Area Code Lease amortization expense Operating Lease, Right-of-Use Asset, Periodic Reduction Expected volatility Measurement Input, Price Volatility [Member] Zelsuvmi Zelsuvmi [Member] Zelsuvmi Name Forgone Recovery, Individual Name Contingent consideration, number of net sales achievements Asset Acquisition, Contingent Consideration, Number Of Net Sales Achievements Asset Acquisition, Contingent Consideration, Number Of Net Sales Achievements Manufacturing and laboratory equipment Manufacturing And Laboratory Equipment [Member] Manufacturing And Laboratory Equipment Bloomberg B- yield curve Debt Instrument, Bloomberg B- Yield Curve, Percent Debt Instrument, Bloomberg B- Yield Curve, Percent Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted- Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Entity [Domain] Entity [Domain] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Contractual Obligation [Roll Forward] Contractual Obligation [Roll Forward] Contractual Obligation Proceeds from convertible note Proceeds from Convertible Debt Shares issued in PIPE Financing (in shares) Stock Issued During Period, Shares, New Issues ORGANIZATION AND DESCRIPTION OF BUSINESS Nature of Operations [Text Block] Customer Three Customer Three [Member] Customer Three Share-based payment arrangement, expense Stock-based compensation Share-Based Payment Arrangement, Expense Reedy Creek Purchase Agreement Reedy Creek Purchase Agreement [Member] Reedy Creek Purchase Agreement Preferred stock conversion ratio Preferred Stock, Convertible, Conversion Ratio Inventory Business Combination, Recognized Asset Acquired, Inventory, Current Exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Subsequent Event Type [Domain] Subsequent Event Type [Domain] UNC License Agreement UNC License Agreement [Member] UNC License Agreement Revision of Prior Period [Domain] Revision of Prior Period [Domain] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Preferred stock series A Series A Preferred Stock [Member] Cash and cash equivalents Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Payment of venture loan and security agreement issuance costs Payments of Debt Issuance Costs Sale of stock, authorized amount Sale Of Stock, Authorized Amount Sale Of Stock, Authorized Amount Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Error Corrections and Prior Period Adjustments Restatement [Line Items] Error Corrections and Prior Period Adjustments Restatement [Line Items] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Schedule of Consideration in Merger Business Combination [Table Text Block] Schedule of Pro Forma Information Business Combination, Pro Forma Information [Table Text Block] Research and development Research and development Research and Development Expense Adjustments to reconcile net loss to net cash used in operating activities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] 2029 Long-Term Debt, Maturity, Year Three PIPE Investors PIPE Investors [Member] PIPE Investors Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Cash flow from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Property and equipment, net Total property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Debt instrument, milestone, trailing 12-month net revenue, minimum Debt Instrument, Milestone, Trailing 12-Month Net Revenue, Minimum Debt Instrument, Milestone, Trailing 12-Month Net Revenue, Minimum Line of credit facility, unused capacity, commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Contract termination without cause, advance written notice period Revenue from Contract with Customer, Contract Termination Without Cause, Advance Written Notice Period Revenue from Contract with Customer, Contract Termination Without Cause, Advance Written Notice Period Intangible Asset, Finite-Lived, Class [Axis] Intangible Asset, Finite-Lived, Class [Axis] Operating lease liabilities, current portion Business Combination, Recognized Liability Assumed, Operating Lease Liabilities, Current Business Combination, Recognized Liability Assumed, Operating Lease Liabilities, Current GOODWILL AND INTANGIBLE ASSETS Intangible Asset and Goodwill [Text Block] Underlying Securities Award Underlying Securities Amount SATO AGREEMENT Revenue from Contract with Customer [Text Block] Preferred stock conversion maximum ownership percentage Preferred Stock, Conversion, Maximum Ownership Percentage Preferred Stock, Conversion, Maximum Ownership Percentage Preferred Shares Preferred Stock [Member] Preferred Stock (Series A) Issued - Merger (in shares) Stock Issued During Period, Shares, Acquisitions Inventory Increase (Decrease) in Inventories Number of milestone payments due License Agreement, Number of Milestone Payments Due License Agreement, Number of Milestone Payments Due Segment Reporting [Table] Segment Reporting [Table] Number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Debt Instrument, Repayment, Period [Domain] Debt Instrument, Repayment, Period [Domain] Debt Instrument, Repayment, Period [Domain] Related Party Transaction [Table] Related Party Transaction [Table] Computer equipment Computer Equipment [Member] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Fair value of convertible note at December 31, 2025 Fair value of convertible note at June 30, 2026 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Current Fiscal Year End Date Current Fiscal Year End Date Total Debt Instruments And Warrants, Fair Value Allocation, Net Debt Instruments And Warrants, Fair Value Allocation, Net Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Offering cost, expense Offering Cost, Expense Schedule of Share-Based Payment Arrangement, Option, Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Measure: Measure [Axis] Amortization of debt discount Amortization of Debt Discount (Premium) Commercial milestone payments License Agreement, Commercial Milestone Payments License Agreement, Commercial Milestone Payments Milestones and royalties payable Accrued Royalties, Current Operating lease liabilities, long-term portion Business Combination, Recognized Liability Assumed, Operating Lease Liabilities, Noncurrent Business Combination, Recognized Liability Assumed, Operating Lease Liabilities, Noncurrent Xepi Xepi Xepi Transaction Intangible Asset [Member] Xepi Transaction Intangible Asset Equity Components [Axis] Equity Components [Axis] Royalty agreement, purchase price Royalty Agreement, Purchase Price Royalty Agreement, Purchase Price Related Party Related Party [Member] Schedule of Asset Acquisition Asset Acquisition [Table Text Block] Cash paid for income taxes Income Tax Paid, after Refund Received Entity Interactive Data Current Entity Interactive Data Current Entity Small Business Entity Small Business Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Debt Discount Debt Instrument, Unamortized Discount Property, Plant, and Equipment [Line Items] Property, Plant, and Equipment [Line Items] Acquired finite-lived intangible assets, weighted average useful life Remaining Useful Life (Years) Intangible Asset, Finite-Lived, Acquired, Weighted-Average Amortization Period Reedy Creek Purchase Agreement Reedy Creek License [Member] Reedy Creek License Deposits for meetings and conferences Deposits Assets, Current MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Percentage of milestone payment retained by company Debt Instrument, Percentage Of Milestone Payment Retained By Company Debt Instrument, Percentage Of Milestone Payment Retained By Company Document Type Document Type Percentage applicable under agreement Research and Development Arrangement, Ongoing Quarterly Payment, Fees Or Milestone Payments, Percentage Research and Development Arrangement, Ongoing Quarterly Payment, Fees Or Milestone Payments, Percentage Net Proceeds Proceeds From PIPE, Net Proceeds From PIPE, Net Payment-in-kind on convertible debt Paid-in-Kind Interest Debt Instrument, Repayment, Period One Debt Instrument, Repayment, Period One [Member] Debt Instrument, Repayment, Period One Exercisable intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Deferred revenue, net of current portion Contract with Customer, Liability, Noncurrent June 30, 2026 Effective Annual Discount Rate Contractual Obligation, Liability, Effective Annual Discount Rate Contractual Obligation, Liability, Effective Annual Discount Rate Net loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Warrant term Warrants and Rights Outstanding, Term Commitments and contingencies (Note 11) Commitments and Contingencies Schedule of Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Property and equipment, cost Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Warrants, measurement input Warrants and Rights Outstanding, Measurement Input 2030 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four LNHC security holders LNHC Security Holders, Prior to Merger [Member] LNHC Security Holders, Prior to Merger Executive Category: Executive Category [Axis] Schedule of Nonvested Restricted Stock Units Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] First Commercial Sale First Commercial Sale [Member] First Commercial Sale Counterparty Name [Axis] Counterparty Name [Axis] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Probability of success Measurement Input, Probability Of Success [Member] Measurement Input, Probability Of Success Inventory Total inventory Inventory, Net Estimated annual effective tax rate Estimated Annual Effective Income Tax Rate, Percent Estimated Annual Effective Income Tax Rate, Percent Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Warrants outstanding (in shares) Class of Warrant or Right, Outstanding Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] PEO Name PEO Name License and supply agreement, notice of termination, minimum period before end of term License And Supply Agreement, Notice Of Termination, Minimum Period Before End Of Term License And Supply Agreement, Notice Of Termination, Minimum Period Before End Of Term Leasehold improvements Leasehold Improvements [Member] Customer One Customer One [Member] Customer One Consideration to investors, percent royalty on net sales Debt Instrument, Consideration To Investors, Percent Royalty On Net Sales Debt Instrument, Consideration To Investors, Percent Royalty On Net Sales Long-Lived Asset, Class [Axis] Long-Lived Asset, Class [Axis] Xepi Royalty Agreement Xepi License [Member] Xepi License Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Accounts payable Change in accounts payable Increase (Decrease) in Accounts Payable Other Other Accrued Liabilities, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Debt Instrument [Axis] Debt Instrument [Axis] Research and development arrangement, liability, fair value Other long-term liabilities Business Combination, Recognized Liability Assumed, Other Liability, Noncurrent Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Consideration to be transferred, contingent consideration Asset Acquisition, Consideration To Be Transferred, Contingent Consideration Asset Acquisition, Consideration To Be Transferred, Contingent Consideration Shares issued for conversion of notes & conversion of preferred A shares (in shares) Conversion of preferred stock (in shares) Preferred Stock (Series A) Converted to Common Stock (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Net loss per common share, basic (in dollars per share) Earnings Per Share, Basic Measurement Input Type [Axis] Measurement Input Type [Axis] Intellectual Property Intellectual Property [Member] Total current assets Assets, Current Insider Trading Arrangements [Line Items] Intangible Asset, Indefinite-Lived, Acquired [Line Items] Intangible Asset, Indefinite-Lived, Acquired [Line Items] Pledge agreement, accrued liabilities for payments, maximum Pledge Agreement, Accrued Liabilities For Payments, Maximum Pledge Agreement, Accrued Liabilities For Payments, Maximum Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] Cover [Abstract] Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Assignment agreement, percentage of milestone payments payable Assignment Agreement, Percentage Of Milestone Payments Payable Assignment Agreement, Percentage Of Milestone Payment Received By Counterparty, Receivable, Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Concentration risk (in percent) Concentration Risk, Percentage Occurrence Of Obtaining $35,000 Threshold in Net Sales For Four Consecutive Quarters Occurrence Of Obtaining $35,000 Threshold in Net Sales For Four Consecutive Quarters [Member] Occurrence Of Obtaining $35,000 Threshold in Net Sales For Four Consecutive Quarters Equity Awards Adjustments Equity Awards Adjustments [Member] LICENSE AND OTHER AGREEMENTS Collaborative Arrangement Disclosure [Text Block] Asset Acquisition [Line Items] Asset Acquisition [Line Items] Sai Rangarao [Member] Sai Rangarao Accrued interest on related party convertible notes payable (Note 7) Accrued interest on Convertible Notes Interest Payable, Noncurrent Interest Payable, Noncurrent Notes Payable Notes Payable, Other Payables [Member] Plan Name [Axis] Plan Name [Axis] Company's security holders Company's Security Holders, Prior to Merger [Member] Company's Security Holders, Prior to Merger Definite-lived intangible assets Intangible Asset, Finite-Lived, after Accumulated Amortization [Abstract] Royalty Event [Axis] Royalty Event [Axis] Royalty Event Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period General and administrative expense General and Administrative Expense Shares issued for conversion of notes Stock Issued During Period, Value, Conversion of Convertible Securities Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Class of Stock [Domain] Class of Stock [Domain] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Series A Preferred Stock per share price (in dollars per share) Business Combination, Consideration Transferred, Equity Interest, Price Per Share Business Combination, Consideration Transferred, Equity Interest, Price Per Share Various Various [Member] Various Schedule of Stock by Class Schedule of Stock by Class [Table Text Block] Stock split (in shares) Stock Issued During Period, Shares, Stock Splits Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Vested and expected (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Richard Malamut [Member] Richard Malamut INCOME TAXES Income Tax Disclosure [Text Block] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Ongoing quarterly payment, percentage Research and Development Arrangement, Ongoing Quarterly Payment, Percentage Research and Development Arrangement, Ongoing Quarterly Payment, Percentage Entity Filer Category Entity Filer Category Asset acquisition, price of acquisition, expected Asset Acquisition, Price of Acquisition, Expected Revision of Prior Period [Axis] Revision of Prior Period [Axis] Other Other Prepaid Expenses And Other Current Assets, Current Other Prepaid Expenses And Other Current Assets, Current Additional borrowing capacity Line of Credit Facility, Accordion Feature Increase Limit Line of Credit Facility, Accordion Feature Increase Limit Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Entity Address, Address Line Two Entity Address, Address Line Two Stock, Class of Stock [Table] Stock, Class of Stock [Table] Royalty payments accrued Contractual Obligation, Liability, Payments Accrued Contractual Obligation, Liability, Payments Accrued Total revenue Business Combination, Pro Forma Information, Pro Forma Revenue Channel Products Royalty Agreement Channel Products Royalty Agreement [Member] Channel Products Royalty Agreement Entity Address, Address Line One Entity Address, Address Line One Warrants, allocated fair value Warrant Liability, Fair Value Allocation, Amount Warrant Liability, Fair Value Allocation, Amount Impairment of intangible assets Intangible Asset, Finite-Lived, Impairment Loss Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Provision for income taxes Income Tax Expense (Benefit) Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Convertible notes payable Convertible Notes Payable [Member] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Principles of Consolidation Consolidation, Policy [Policy Text Block] Accretion of interest for royalty obligations Accretion Expense Deferred tax liability Business Combination, Recognized Liability Assumed, Deferred Tax Liability Discounted Cash Flows Valuation Technique, Discounted Cash Flow [Member] Statement [Table] Statement [Table] Proceeds from issuance initial public offering Proceeds from Issuance Initial Public Offering Conversion of notes to common stock Converted principal amount Debt Conversion, Converted Instrument, Amount Xepi Transaction - Transaction Expenses Asset Acquisition, Consideration Transferred, Transaction Cost Line of credit facility, percentage, final payment Line of Credit Facility, Commitment Fee Percentage, Final Payment Line of Credit Facility, Commitment Fee Percentage, Final Payment Loss contingency, damages sought, value Loss Contingency, Damages Sought, Value Royalty Event [Domain] Royalty Event [Domain] Royalty Event [Domain] BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Significant Accounting Policies [Text Block] Prepaid expenses and other current assets Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current